422 related articles for article (PubMed ID: 33962064)
1. Lysosomal alkalization to potentiate eradication of intra-osteoblastic Staphylococcus aureus in the bone and joint infection setting.
Abad L; Chauvelot P; Audoux E; Andre C; Josse J; Dupieux C; Lustig S; Ferry T; Verhoeven PO; Diot A; Laurent F; Valour F
Clin Microbiol Infect; 2022 Jan; 28(1):135.e1-135.e7. PubMed ID: 33962064
[TBL] [Abstract][Full Text] [Related]
2. Antimicrobial activity against intraosteoblastic Staphylococcus aureus.
Valour F; Trouillet-Assant S; Riffard N; Tasse J; Flammier S; Rasigade JP; Chidiac C; Vandenesch F; Ferry T; Laurent F
Antimicrob Agents Chemother; 2015 Apr; 59(4):2029-36. PubMed ID: 25605365
[TBL] [Abstract][Full Text] [Related]
3. Intraosteoblastic activity of daptomycin in combination with oxacillin and ceftaroline against MSSA and MRSA.
Dupieux C; Trouillet-Assant S; Camus C; Abad L; Bes M; Benito Y; Chidiac C; Lustig S; Ferry T; Valour F; Laurent F
J Antimicrob Chemother; 2017 Dec; 72(12):3353-3356. PubMed ID: 28961767
[TBL] [Abstract][Full Text] [Related]
4. Intraosteoblastic activity of levofloxacin and rifampin alone and in combination against clinical isolates of meticillin-susceptible Staphylococcus aureus causing prosthetic joint infection.
Meléndez-Carmona MÁ; Muñoz-Gallego I; Viedma E; Lora-Tamayo J; Chaves F
Int J Antimicrob Agents; 2019 Sep; 54(3):356-360. PubMed ID: 31254616
[TBL] [Abstract][Full Text] [Related]
5. Activities of clindamycin, daptomycin, doxycycline, linezolid, trimethoprim-sulfamethoxazole, and vancomycin against community-associated methicillin-resistant Staphylococcus aureus with inducible clindamycin resistance in murine thigh infection and in vitro pharmacodynamic models.
LaPlante KL; Leonard SN; Andes DR; Craig WA; Rybak MJ
Antimicrob Agents Chemother; 2008 Jun; 52(6):2156-62. PubMed ID: 18411321
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of novel anti-MRSA cephalosporins and comparator antimicrobial agents against staphylococci involved in prosthetic joint infections.
Isnard C; Dhalluin A; Malandain D; Bruey Q; Auzou M; Michon J; Giard JC; Guérin F; Cattoir V
J Glob Antimicrob Resist; 2018 Jun; 13():221-225. PubMed ID: 29421316
[TBL] [Abstract][Full Text] [Related]
7. Fusidic acid for the treatment of bone and joint infections caused by meticillin-resistant Staphylococcus aureus.
Wang JL; Tang HJ; Hsieh PH; Chiu FY; Chen YH; Chang MC; Huang CT; Liu CP; Lau YJ; Hwang KP; Ko WC; Wang CT; Liu CY; Liu CL; Hsueh PR
Int J Antimicrob Agents; 2012 Aug; 40(2):103-7. PubMed ID: 22612900
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the novel combination of high-dose daptomycin plus trimethoprim-sulfamethoxazole against daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus using an in vitro pharmacokinetic/pharmacodynamic model of simulated endocardial vegetations.
Steed ME; Werth BJ; Ireland CE; Rybak MJ
Antimicrob Agents Chemother; 2012 Nov; 56(11):5709-14. PubMed ID: 22908167
[TBL] [Abstract][Full Text] [Related]
9. Appropriate oral antibiotics for bone and joint infections based on the susceptibility of clinical Staphylococcus aureus isolates.
Lee CS; Hwang JH; Lee JH; Song SK; Cho JH; Lee JH
Korean J Intern Med; 2015 Mar; 30(2):262-4. PubMed ID: 25750572
[No Abstract] [Full Text] [Related]
10. Evaluation of the ability of linezolid and tedizolid to eradicate intraosteoblastic and biofilm-embedded Staphylococcus aureus in the bone and joint infection setting.
Abad L; Tafani V; Tasse J; Josse J; Chidiac C; Lustig S; Ferry T; Diot A; Laurent F; Valour F
J Antimicrob Chemother; 2019 Mar; 74(3):625-632. PubMed ID: 30517641
[TBL] [Abstract][Full Text] [Related]
11. Efficacy assessment of lysin CF-296 in addition to daptomycin or vancomycin against Staphylococcus aureus in the murine thigh infection model.
Asempa TE; DeRosa NA; Cassino C; Lehoux D; Schuch R; Nicolau DP
J Antimicrob Chemother; 2021 Sep; 76(10):2622-2628. PubMed ID: 34223628
[TBL] [Abstract][Full Text] [Related]
12. Activity of ceftaroline and epidemiologic trends in Staphylococcus aureus isolates collected from 43 medical centers in the United States in 2009.
Richter SS; Heilmann KP; Dohrn CL; Riahi F; Costello AJ; Kroeger JS; Biek D; Critchley IA; Diekema DJ; Doern GV
Antimicrob Agents Chemother; 2011 Sep; 55(9):4154-60. PubMed ID: 21709080
[TBL] [Abstract][Full Text] [Related]
13. Determination of antimicrobial susceptibility patterns in Staphylococcus aureus strains recovered from patients at two main health facilities in Kabul, Afghanistan.
Naimi HM; Rasekh H; Noori AZ; Bahaduri MA
BMC Infect Dis; 2017 Nov; 17(1):737. PubMed ID: 29187146
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory activities of 11 antimicrobial agents and bactericidal activities of vancomycin and daptomycin against invasive methicillin-resistant Staphylococcus aureus isolates obtained from 1999 through 2006.
Holmes RL; Jorgensen JH
Antimicrob Agents Chemother; 2008 Feb; 52(2):757-60. PubMed ID: 18039923
[TBL] [Abstract][Full Text] [Related]
15. No change in the distribution of types and antibiotic resistance in clinical Staphylococcus aureus isolates from orthopaedic patients during a period of 12 years.
Aamot HV; Stavem K; Skråmm I
Eur J Clin Microbiol Infect Dis; 2015 Sep; 34(9):1833-7. PubMed ID: 26076750
[TBL] [Abstract][Full Text] [Related]
16. Levonadifloxacin (WCK 771) exerts potent intracellular activity against
Dubois J; Dubois M
J Med Microbiol; 2019 Dec; 68(12):1716-1722. PubMed ID: 31689174
[No Abstract] [Full Text] [Related]
17. Impact of high-inoculum Staphylococcus aureus on the activities of nafcillin, vancomycin, linezolid, and daptomycin, alone and in combination with gentamicin, in an in vitro pharmacodynamic model.
LaPlante KL; Rybak MJ
Antimicrob Agents Chemother; 2004 Dec; 48(12):4665-72. PubMed ID: 15561842
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of intraosteoblastic activity of dalbavancin against Staphylococcus aureus in an ex vivo model of bone cell infection.
Chauvelot P; Dupieux-Chabert C; Abad L; Souche A; Ferry T; Josse J; Laurent F; Valour F;
J Antimicrob Chemother; 2021 Oct; 76(11):2863-2866. PubMed ID: 34423360
[TBL] [Abstract][Full Text] [Related]
19. Daptomycin in bone and joint infections: a review of the literature.
Rice DA; Mendez-Vigo L
Arch Orthop Trauma Surg; 2009 Nov; 129(11):1495-504. PubMed ID: 18989686
[TBL] [Abstract][Full Text] [Related]
20. [In vitro activity of linezolid, moxifloxacin, levofloxacin, clindamycin and rifampin, alone and in combination, against Staphylococcus aureus and Staphylococcus epidermidis].
Soriano A; Jurado A; Marco F; Almela M; Ortega M; Mensa J
Rev Esp Quimioter; 2005 Jun; 18(2):168-72. PubMed ID: 16130039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
